Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-655-6 | CAS number: 537-01-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
There are three forms of lanthanides:
insoluble (oxides, carbonates), solubles (chlorides, nitrates, acetates)
and chelated compounds.
Cerium carbonate is a realtively insoluble form or cerium, as
illustrated by its very low water solubility (3.95 + 0.2 mg/L at 20° C).
Most of the available information on lanthanides absorption, comes from
the soluble lanthanides salts. Different forms of lanthanides have
different organ distribution and excretion rates.
The lanthanides carbonates and oxides have been shown in in vitro
bioaccessibility studies to have a very low gastrointestinal
bioaccessibility of ~6% (Lambert CE, 2005).
The following basic toxicokinetic information can be extrapolated from
the experimental toxicology data available on dicerium tricarbonate, an
insoluble inorganic substance:
- Regarding its absorption:
Following a single administration either by oral route (at the limit dose of 5000 mg/kg) or dermal route (at the limit dose of 2000 mg/kg), no relevant systemic clinical sign or changes in body weight were observed. No specific study on dermal absorption is available. However, as cerium carbonate is an insoluble inorganic test substance (no log P can be calculated), no significant dermal absorption is expected. As an illustration, following acute exposure of rats to a dermal dose of 2000 mg/kg and observation up to 14 days following application, no noteworthy systemic clinical sign was observed.
Following repeated dose administration by the oral route at doses up to the limit dose of 1000 mg/kgbw/day of dicerium tricarbonatefor up to approximately 42 days in male rats and 54 days in female rats,there wasno relevant sign of toxicity in clinical signs, functional observational battery, body weight,andfood consumption. However, there was some evidence of absorption as changes in haematology/clinical chemistry was observed in male and female animals treated atthe highest dose tested1000 mg/kg bw/dayand no effect were observed at the lower doses tested (450 and 150 mg/kg bw/day).Following inhalation exposure for up to 90 days in rats, the effects observedof an analogous (cerium oxide)were consistent with "portal-of-entry" effects and a lung-overload inflammatory response syndrome. No systemic effect resulting from significant absorption was evidenced. The absorption of dicerium tricarbonate is therefore expected to be low.
- Regarding its distribution:
Following repeated dose administration by inhalation (nose only)of the analogous: cerium dioxide at concentrations up to 0.5075 mg/L (507.5 mg/m3) for 13 weeks in rats, only loco-regional "portal-of-entry" effects were observed, as changes in segmented neutrophil counts, lung and spleen weights, lung and lymph node gross appearance at necropsy and respiratory tract and lymphoreticular systemhistopathology. These effects were illustrative of an inflammatory response subsequent to lung overloading with poorly soluble particles, without functional impairment of the immune system. No relevant systemic effects specific to cerium dioxide as such were evidenced.
Therefore, under normal conditions of exposure, no systemic distribution of dicerium tricarbonate is expected.
- Regarding its metabolism:
The presence or absence of exogenous metabolic activation system made no difference in the results of in vitro mutagenicity testing. No conclusion can therefore be made regarding the transformation of the test substance and/or its degradation products or metabolites by hepatic microsomal fractions.
No microscopic finding in the major metabolizing tissues (liver, kidneys) illustrative of metabolic activity were seen following repeated dose administration by the oral route at doses up to the limit dose of 1000 mg/kg for up to approximately 42 days in male rats and 54 days in female rats or by inhalation (nose only)of the analogous substance: cerium oxideat concentrations up to 0.5075 mg/L for 13 weeks in rats.
- Regarding its elimination:
Based on their insoluble nature, low absorption and distribution potentials, and absence of obvious metabolism, it is probable that dicerium tricarbonate will be eliminated under an unmodified form.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.